Skip to main content

Levetiracetam

NDC 27808-265 · Cranbury Pharmaceuticals, LLC

Generic nameLevetiracetam
Dosage formTABLET
RouteORAL
Active ingredient(s)LEVETIRACETAM
Strength750 mg/1
Pharmacologic classDecreased Central Nervous System Disorganized Electrical Activity [PE]
Marketing categoryANDA

Packages

27808-265-01 — 120 TABLET in 1 BOTTLE (27808-265-01)

27808-265-02 — 500 TABLET in 1 BOTTLE (27808-265-02)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

16714-035 — Levetiracetam, 16714-310 — Levetiracetam, 16714-358 — Levetiracetam, 16714-537 — Levetiracetam, 17856-0574 — Levetiracetam, 25021-793 — levetiracetam, 25021-794 — levetiracetam, 25021-795 — levetiracetam, 27808-263 — Levetiracetam, 27808-264 — Levetiracetam, 27808-266 — Levetiracetam, 31722-536 — Levetiracetam, 31722-537 — Levetiracetam, 31722-538 — Levetiracetam, 31722-539 — Levetiracetam, 31722-574 — Levetiracetam oral, 36000-352 — levetiracetam, 36000-354 — levetiracetam, 36000-356 — levetiracetam, 39328-511 — Levetiracetam, +277 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources